Myriad Genetics (MYGN) Current Deferred Tax Assets (2010 - 2015)

Myriad Genetics has disclosed Current Deferred Tax Assets across 6 years of filings, most recently posting $13.5 million for Q3 2015.

• In Q3 2015, Current Deferred Tax Assets rose 2.05% year-over-year to $13.5 million; the TTM figure through Sep 2015 stood at $13.5 million (up 2.05% YoY), while the FY2015 annual figure was $13.5 million, up 107.69% from the prior year.
• Current Deferred Tax Assets steadied at $13.5 million in Q3 2015, from $13.5 million in the prior quarter.
• Over the last five years, Current Deferred Tax Assets for MYGN reached as high as $13.5 million in Q2 2015 and fell as low as $4.4 million in Q1 2011.
• The 5-year median for Current Deferred Tax Assets is $8.8 million (2013), against an average of $9.2 million.
• Annual changes were most pronounced in 2011 — Current Deferred Tax Assets tumbled 47.25% — and 2015, when it surged 107.69%.
• A 5-year view of Current Deferred Tax Assets shows it stood at $7.8 million in 2011, then climbed by 20.14% to $9.4 million in 2012, then decreased by 2.99% to $9.1 million in 2013, then soared by 41.21% to $12.8 million in 2014, then increased by 5.36% to $13.5 million in 2015.
• According to Business Quant data, Current Deferred Tax Assets over the past three periods registered $13.5 million, $13.5 million, and $13.5 million for Q3 2015, Q2 2015, and Q1 2015 respectively.